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Primary pulmonary mucinous cystadenocarcinoma (PMCAC) is an extremely rare cystic neoplasm. A case of a 56-year-old male
with a cystic lesion of the right lower lobe is described. Preoperative ﬁne needle aspiration cytology and bronchoscopy were
inconclusive. The patient underwent a formal right lower lobectomy and mediastinal lymph node dissection. Diagnosis was
established intraoperatively. The biological behavior of primary PMCAC is unknown. Therefore, careful long-term follow-up
is considered necessary because of lack of experience globally.
1.Introduction
Primary pulmonary mucinous cystadenocarcinoma (pri-
mary PMCAC) belongs to a group of cystic neoplasms
characterized by extracellular mucin secretion. These muci-
nous neoplasms are histologically similar to well-recognized
mucinous tumors of the ovary, breast, and pancreas [1].
Although it is considered malignant, its biological behavior
is still under study. The incidence of this lesion seems to
be unknown. Very few cases have been published in the
English literature. Preoperative diagnosis is very diﬃcult.
Diagnosis is established in all cases by histopathology of
the resected tumors, although ﬁne needle aspiration (FNA),
bronchial washings, brushings or biopsies may help preop-
eratively [2, 3]. Identiﬁcation of this kind of lesion is very
important because of presumed diﬀerences in management
and prognosis.
2.CasePresentation
A 56-year-old male presented with a complaint of chest
pain. His medical record was clear, except that he was
a heavy smoker (60 cigarettes/day for 38 years). Clinical
examination revealed diminished breath sounds in the right
hemithorax. A chest X-ray showed a large mass in the right
lung(Figure 1(a)).ComputedTomography (CT)ofthe chest
revealed a tumor originating in the right lower lobe, measur-
ing 9.3 × 7.5cm (Figure 1(b)). The lesion had a low atten-
uation (19 Hounsﬁeld Units), and tiny, mildly enhancing
septa was recognized. Mediastinal lymphadenopathy was not
detected, while further brain and abdomen CT scans were
negative.
Bronchoscopy was negative for endobronchial growth,
and CT-guided FNA cytology failed to establish a tissue
diagnosis. The patient underwent a right posterolateral tho-
racotomy, and a right lower lobectomy was performed.
Frozen sections of the specimen revealed a cystic mucinous
mass with ﬁbrous walls containing abundant mucinous
material. Cells suspicious for malignancy were detected
inside the mucin. The operation, therefore, was completed
with a radical mediastinal lymph node dissection. The
patient was discharged on the 11th postoperative day. No
complications were observed.2 Case Reports in Medicine
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Figure 1: Primary PMCAC. (a) Chest X-ray revealing a solitary
tumor in the right lower lobe of the lung. (b) Computed Tomog-
raphy scan ofthe thorax.A large cystic well-demarcated mass in the
right lower lobe of the lung is detected (19 Hounsﬁeld Units).
The excised lobe contained a cystic tumor ﬁlled with
mucin, 9.3cm in greater diameter. Microscopic exami-
nation revealed a well-diﬀerentiated mucinous cystadeno-
carcinoma. The tumor consisted of a large cystic space
ﬁlled with mucin, and many smaller cysts along its wall
(Figure 2). The cysticspaces were lined by one ormore layers
of columnar, mucous-secreting cells with atypia, and few
mitoses. The mucinpoolswere frequentlydissecting through
the surrounding stroma. In addition, small irregular groups
of neoplastic cells were found to invade the surrounding
stroma. The visceral pleura and the surgical margin of the
lobar bronchus were free of tumor. All twenty-two removed
lymph nodes (interlobar, hilar, and ipsilateral mediastinal)
were also negative. In order to exclude the possibility of a
Figure 2: Primary PMCAC. The tumor consists of a large
cystic space ﬁlled with mucin and lined by columnar neoplastic
epithelium. (H&E, 25X).
metastatic adenocarcinoma, immunohistochemical investi-
gationfollowed.Thetumorcellswerepositiveforcytokeratin
7 and negative for cytokeratin 20 and Thyroid Transcription
Factor-1 (TTF-1). Retrospective review of both broncho-
scopic and FNA ﬁndings suggests that a correct preoperative
diagnosis was impossible.
The patient is currently been followed up closely. No
signs of local or distal recurrence were observed during 6-
months period.
3.Discussion
Primary PMCAC is a very rare entity. It was ﬁrst described
in 1978 by Sambrook Gowar [4]. It is considered to be
the pulmonary counterpart of similar tumors in the ovary,
breast, and pancreas. In the majority of the published
cases, the patients were asymptomatic, and the tumor was
discovered incidentallyby performing a chest X-ray forother
reason. Hemoptysis, recurrent bronchitis, and exacerbation
of chronic obstructive pulmonary disease in three cases were
reported as the initial clinical manifestation [5]. Thoracic
pain was the chief complaint in our case.
Radiologically, some authors mention CT characteristics
which can raise suspicion for the diagnosis. These include a
uniform low attenuation cystic lesion with focal thickening
and enhancement of the walls and septa [6]. CT images of
our patient ﬁt perfect in the above description. Furthermore,
congenital diseases such as pulmonary sequestration, bron-
chogenic cyst, or bronchocele, infectious causes like hydatid
cyst or abscess, and some types of other cystic neoplasms,
primary or metastatic, complete the radiological diﬀerential
diagnosis [7].
The normal bronchial mucusis 95–98% water and 2–5%
solids, and the majority of the solid component is formed by
glycoproteins. Due to its high water content, mucus has CT
attenuation and Magnetic Resonance Imaging (MRI) signal
similar tothoseofwateranddonotenhanceafterinjectionof
intravenous contrast medium; however, a chronic entrappedCase Reports in Medicine 3
mucus collection can undergo a gradual transformation.
The increased production of mucus protein is accompanied
by a gradual reabsorption of water with a decrease in free
water content and an increase in protein concentration.
Protein concentration inﬂuences the T1 relaxation time, and
an elevation in protein concentration may cause impressive
shortening of the T1 relaxation time. Mucus with a protein
level >9,000mg/dL has high signal intensity on T1-weighted
images. The detection of mucus within a mediastinal or
pulmonary lesion is important because it permits shortening
of the list of diﬀerential diagnoses [8].
It has been well known that most malignant tumors
have a higher rate of glucose metabolism than normal
tissue. However, 18Fluoro-2-deoxy-D-glucose(FDG) uptake
has a wide variation in tumor glucose metabolic rate,
depending on the histologic type and aggressiveness of the
tumor. Because FDG behaves as an analog of glucose, its
distributioncloselyfollowsthatofglucose-metabolizing cells
and organs. Most malignant tumors have a higher rate of
glucose metabolism than normal tissue, therefore, exhibit
a higher FDG uptake than background tissue. Using FDG
Positron Emission Tomography (PET) a positive correlation
between tumor FDG uptake and cellularity can be proved,
but a negative correlation with the amount of mucin is
also expected. In case of PMCAC hypocellular lesion with
abundant mucin, it is possible that little FDG uptake on
integrated PET/CT be shown [9]. In addition, Yap et al.
mentioned that noninvasive feature of tumor made negative
FDG PET ﬁndings of tumor as well as mucin [10].
The histopathological diﬀerential diagnosis of primary
PMCAC includes primary lesions of the lung and metastatic
tumors from other organs, especially the ovary, breast, and
pancreas [11]. Well-diﬀerentiated mucinous bronchoalveo-
lar carcinoma is usually solid and has the ability to develop
in association with a preexisting lung cavity. In mucoepi-
dermoid carcinoma squamous and intermediate cells in
combination are almost always present. Solitary metastatic
mucinous tumors can mimic primary PMCAC; therefore,
full investigation of the organs that may develop this kind of
carcinoma is obligatory [12].Mucinouscystadenocarcinoma
of the lung represents an entity with two distinct clini-
copathologic and immunophenotypic variants: the goblet
cell-type, presenting a more indolent clinical behavior and
frequentlycoexpressing markers of intestinal and pulmonary
diﬀerentiation and the more aggressive signet-ring cell type,
which retains only markers of pulmonary origin [13].
Nonneoplasticlesionsthatenterthediﬀerentialdiagnosis
include developmental bronchogenic cysts and congenital
adenomatoid malformations. Both can have foci of muci-
nous epithelium but more commonly are lined by ciliated
columnar epithelium, in contrast with the purely mucinous
epitheliumofmucinouscystictumors. Developmentalbron-
chogenic cysts are extrapulmonary, located in the midline,
and have a ﬁbromuscular wall containing cartilage and
seromucinous glands [5].
Preoperative diagnosis is very diﬃcult to establish. Both
FNA cytology and transbronchial lung biopsy seem inade-
quate, mainly because the malignant cells are ﬂoating inside
the mucin. Only in two cases were the authors able to reach
preoperative diagnosis by using FNA cytology [2, 3]. In our
case both bronchoscopy and CT-guided FNA proved to be
ineﬃcient. As a result the surgical approach was mandatory.
Frozen section revealed atypical cells inside the mucin. Their
characteristics were compatible with a primary PMCAC.
The biological behavior of primary PMCAC is generally
unknown. Although it is considered a malignant tumor, it
seems not to have malignant potential of high degree. In
the only case where recurrence occurred, margin negative
wedge resection was performed at ﬁrst. Due to the small
number of reported cases in the literature, the tumor’s
developing pattern is not yet completely clariﬁed. It seems,
however, that local extension is more likely than distal
metastases. Therefore, formal anatomic lobectomy for early
stage tumors, in those patients who can physiologically
withstand it, according to GN Mann et al, is probably the
correct surgical approach [14]. The role of chemotherapy
and radiotherapy is diﬃcult to deﬁne because of the small
number of cases and unclear natural history. Based on that,
close long-term follow-up is obligatory.
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